Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up

Tekcapital sees portfolio company Salarius benefitting from FDA salt reduction goals

Thu, 14th Oct 2021

Tekcapital said its portfolio company Salarius could benefit from the the U.S. Food and Drug Administration goals to reduce the amount of salt in commercially processed, packaged, and prepared foods. 'We believe the FDA guidelines will encourage snack food manufactures to reduce the sodium levels in their products across the board,' the company said. Portfolio company Salarius anticipates this 'should have a positive impact on both B2B sales of MicroSalt and retail sales of SaltMe! crisps,' it added. MicroSalt aims to revolutionize the food industry with its patented sodium microparticle, that delivers the full-flavour experience of salt with roughly half the sodium. Story provided by StockMarketWire.com

FTSE 100 Latest
Value7,221.20
Change17.37